Skip to the content
FSHD Europe

FSHD Europe

FSHD

  • Home
  • About Us
    • Member Organisations
    • Contact
    • Who we are…
      • Sheila Hawkins
      • Paola de Donato
  • News
    • Events
    • Stories
  • What is FSHD
  • FSHD European Trial Network
    • What is it about?
    • Core Group of Experts
  • Research
    • Guidelines
    • Clinical trials
  • Governance
    • Policies
    • Financial Reports
    • Statutes
  • Links
Clinical trials

An update on the impact of COVID-19 on the Fulcrum clinical trials

April 8, 2020 By Diana Kim-vdMeij
In the current global situation, it is also a challenge for companies like Fulcrum Therapeutics to continue clinical trials in times of the Covid-19 pandemic while protecting participants and clinical staff. Here is a brief update:Download

Post navigation

Previous PostPrevious Information for people with FSHD regarding Covid-19
Next PostNext Latest Research News – Events of the FSHD Society in late June/early July 2020
Proudly powered by WordPress | Theme: Popularis